Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | SPR | P35270 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5190758 | 0.86 | SPR (0.52) | KDM4ERAB9AADRA2BHDAC4MEF2D | |
| SCHEMBL25442716 | 0.83 | MEN1 (0.57) | KDM4ERAB9AKMT2AALDH1A1MAPT | |
| SCHEMBL7159240 | 0.82 | EGFR (0.54) | KDM4EEGFRKMT2AALDH1A1MAPT | |
| SCHEMBL30520309 | 0.80 | KDM4E (0.59) | KDM4ERAB9ALTA4HKMT2AALDH1A1 | |
| SCHEMBL3254598 | 0.80 | KDM4E (0.59) | KDM4ERAB9ALTA4HKMT2AALDH1A1 | |
| SCHEMBL2991426 | 0.78 | EGFR (0.62) | ADRA2BEGFRALDH1A1MAPTTDP1 | |
| Hydrochloric Acid SCHEMBL2990403 | 0.77 | EGFR (0.61) | EGFRALDH1A1MAPTTDP1PRKCI | |
| Hydrochloric Acid SCHEMBL6516882 | 0.77 | EGFR (0.53) | EGFRALDH1A1MAPTTDP1 | |
| SCHEMBL7158020 | 0.75 | CA12 (0.50) | EGFRKMT2AALDH1A1MAPTGAA | |
| SCHEMBL7160030 | 0.75 | MAPT (0.68) | KDM4EEGFRKMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1449276-A | Primary intermediates for oxidative dyeing of hair | P & G CLAIROL INC (US) | 2003-10-15 | — | — | CN | claimed |
| EP-1331918-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | Clairol Incorporated (US) | 2003-08-06 | — | — | EP | claimed |
| US-6562080-B2 | 2-arylaminomethyl-4-aminophenols; light fastness, fastness to shampooing, fastness to permanent wave treatment | CLAIROL INCORPORATED | 2003-05-13 | — | — | US | claimed |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-10 | — | — | US | claimed |
| WO-2002017866-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-03-07 | — | — | WO | claimed |
| US-12133906-B2 | Delivery particle | THE PROCTER & GAMBLE COMPANY (US) | 2024-11-05 | — | — | US | disclosed |
| US-20220409497-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2022-12-29 | — | — | US | disclosed |
| EP-3733827-A1 | DELIVERY PARTICLES | The Procter & Gamble Company (US) | 2020-11-04 | — | — | EP | disclosed |
| EP-2563508-B1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-07-10 | — | — | EP | disclosed |
| EP-1642563-B1 | Method of rapid hair dyeing | NOXELL CORP (US) | 2019-06-26 | — | — | EP | disclosed |
| US-20190142714-A1 | DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2019-05-16 | — | — | US | disclosed |
| EP-1484048-B1 | Hair colouring compositions | NOXELL CORP (US) | 2019-01-02 | — | — | EP | disclosed |
| EP-1331918-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | Clairol Incorporated (US) | 2003-08-06 | — | — | EP | disclosed |
| US-6562080-B2 | 2-arylaminomethyl-4-aminophenols; light fastness, fastness to shampooing, fastness to permanent wave treatment | CLAIROL INCORPORATED | 2003-05-13 | — | — | US | disclosed |
| US-6540793-B1 | Coupler for use in oxidative hair dyeing | CLAIROL INCORPORATED | 2003-04-01 | — | — | US | disclosed |
| CN-1396819-A | Novel couplers for oxidative hair dyeing | P & G CLAROR INC (US) | 2003-02-12 | — | — | CN | disclosed |
| EP-1251822-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | Clairol Incorporated (US) | 2002-10-30 | — | — | EP | disclosed |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | WELLA OPERATIONS US, LLC | 2002-10-10 | — | — | US | disclosed |
| WO-2002017866-A1 | PRIMARY INTERMEDIATES FOR OXIDATIVE COLORATION OF HAIR | P&G-CLAIROL, INC. (US) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001056538-A1 | NOVEL COUPLER FOR USE IN OXIDATIVE HAIR DYEING | P&G-CLAIROL, INC. (US) | 2001-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220409497-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | KDM4E 4662/4885RAB9A 2130/4885ADRA2B 736/4885 |
| US-20020144355-A1 | Primary intermediates for oxidative coloration of hair | CYC1, CBR1, CBR3 | KDM4E 1002/4885RAB9A 4317/4885ADRA2B 1549/4885 |
| US-12133906-B2 | Delivery particle | LIPA, CHMP4B, SLC46A1 | KDM4E 4662/4885RAB9A 2130/4885ADRA2B 736/4885 |
| US-20190142714-A1 | DELIVERY PARTICLE | LIPA, CHMP4B, SLC46A1 | KDM4E 4662/4885RAB9A 2130/4885ADRA2B 736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.